Selective tumoricidal effect of soluble proteoglucan extracted from the basidiomycete, Agaricus blazei Murill, mediated via natural killer cell activation and apoptosis (original) (raw)
Abstract
We have isolated a novel type of natural tumoricidal product from the basidiomycete strain, Agaricus blazei Murill. Using the double-grafted tumor system in Balb/c mice, treatment of the primary tumor with an acid-treated fraction (ATF) obtained from the fruit bodies resulted in infiltration of the distant tumor by natural killer (NK) cells with marked tumoricidal activity. As shown by electrophoresis and DNA fragmentation assay, the ATF also directly inhibited tumor cell growth in vitro by inducing apoptotic processing; this apoptotic effect was also demonstrated by increased expression of the Apo2.7 antigen on the mitochondrial membranes of tumor cells, as shown by flow-cytometric analysis. The ATF had no effect on normal mouse splenic or interleukin-2-treated splenic mononuclear cells, indicating that it is selectively cytotoxic for the tumor cells. Cell-cycle analysis demonstrated that ATF induced the loss of S phase in MethA tumor cells, but did not affect normal splenic mononuclear cells, which were mainly in the G0G1 phase. Various chromatofocussing purification steps and NMR analysis showed the tumoricidal activity to be chiefly present in fractions containing (1→4)-α-D-glucan and (1→6)-β-D-glucan, present in a ratio of approximately 1:2 in the ATF (molecular mass 170 kDa), while the final purified fraction, HM3-G (molecular mass 380 kDa), with the highest tumoricidal activity, consisted of more than 90% glucose, the main component being (1→4)-α-D-glucan with (1→6)-β branching, in the ratio of approximately 4:1.
Access this article
Subscribe and save
- Get 10 units per month
- Download Article/Chapter or eBook
- 1 Unit = 1 Article or 1 Chapter
- Cancel anytime Subscribe now
Buy Now
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Instant access to the full article PDF.
Similar content being viewed by others
Author information
Authors and Affiliations
- Division of Immunology, Miyagi Cancer Center Research Institute, Natori, Japan 9811293, , , , , , JP
Yoshiaki Fujimiya & Takusaburo Ebina - Division of Neurosurgery, Miyagi Cancer Center Research Institute, Natori, Japan 9811293, , , , , , JP
Youichi Suzuki & Ryuichi Katakura - Division of Biotechnology, Sumitomo Forestry Tsukuba Research Institute, Tsukuba, Ibaraki, Japan 3002646, , , , , , JP
Ko-ichi Oshiman, Hidekazu Kobori & Shogo Takahara - Division of Scientific Instrument, Sumika Chemical Analysis Service, Inc., Osaka, Japan 5540022, , , , , , JP
Koichi Moriguchi, Hisako Nakashima & Yonezo Matumoto
Authors
- Yoshiaki Fujimiya
You can also search for this author inPubMed Google Scholar - Youichi Suzuki
You can also search for this author inPubMed Google Scholar - Ko-ichi Oshiman
You can also search for this author inPubMed Google Scholar - Hidekazu Kobori
You can also search for this author inPubMed Google Scholar - Koichi Moriguchi
You can also search for this author inPubMed Google Scholar - Hisako Nakashima
You can also search for this author inPubMed Google Scholar - Yonezo Matumoto
You can also search for this author inPubMed Google Scholar - Shogo Takahara
You can also search for this author inPubMed Google Scholar - Takusaburo Ebina
You can also search for this author inPubMed Google Scholar - Ryuichi Katakura
You can also search for this author inPubMed Google Scholar
Additional information
Received: 27 August 1997 / Accepted 22 December 1997
Rights and permissions
About this article
Cite this article
Fujimiya, Y., Suzuki, Y., Oshiman, Ki. et al. Selective tumoricidal effect of soluble proteoglucan extracted from the basidiomycete, Agaricus blazei Murill, mediated via natural killer cell activation and apoptosis.Cancer Immunol Immunother 46, 147–159 (1998). https://doi.org/10.1007/s002620050473
- Issue Date: May 1998
- DOI: https://doi.org/10.1007/s002620050473